Literature DB >> 3387449

cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

A W Bach1, N C Lan, D L Johnson, C W Abell, M E Bembenek, S W Kwan, P H Seeburg, J C Shih.   

Abstract

The monoamine oxidases play a vital role in the metabolism of biogenic amines in the central nervous system and in peripheral tissues. Using oligonucleotide probes derived from three sequenced peptide fragments, we have isolated cDNA clones that encode the A and B forms of monoamine oxidase and have determined the nucleotide sequences of these cDNAs. Comparison of the deduced amino acid sequences shows that the A and B forms have subunit molecular weights of 59,700 and 58,800, respectively, and have 70% sequence identity. Both sequences contain the pentapeptide Ser-Gly-Gly-Cys-Tyr, in which the obligatory cofactor FAD is covalently bound to cysteine. Based on differences in primary amino acid sequences and RNA gel blot analysis of mRNAs, the A and B forms of monoamine oxidase appear to be derived from separate genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3387449      PMCID: PMC280552          DOI: 10.1073/pnas.85.13.4934

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Studies on monoamine oxidase. XVIII. Enzymic properties of placental monoamine oxidase.

Authors:  T Egashira
Journal:  Jpn J Pharmacol       Date:  1976-08

2.  Properties of monoamine oxidase (MAO) in human blood platelets, plasma, lymphocytes and granulocytes.

Authors:  P A Bond; R L Cundall
Journal:  Clin Chim Acta       Date:  1977-10-15       Impact factor: 3.786

3.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

Authors:  C H Donnelly; D L Murphy
Journal:  Biochem Pharmacol       Date:  1977-05-01       Impact factor: 5.858

4.  Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain.

Authors:  L W Thorpe; K N Westlund; L M Kochersperger; C W Abell; R M Denney
Journal:  J Histochem Cytochem       Date:  1987-01       Impact factor: 2.479

5.  The covalently-bound flavin of hepatic monoamine oxidase. 1. Isolation and sequence of a flavin peptide and evidence for binding at the 8alpha position.

Authors:  E B Kearney; J I Salach; W H Walker; R L Seng; W Kenney; E Zeszotek; T P Singer
Journal:  Eur J Biochem       Date:  1971-12

6.  Mitochondrial monoamine oxidase. Inactivation by pargyline. Adduct formation.

Authors:  H Y Chuang; D R Patek; L Hellerman
Journal:  J Biol Chem       Date:  1974-04-25       Impact factor: 5.157

7.  Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

Authors:  J P Johnston
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

8.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

9.  Bovine liver monoamine oxidase. A modified purification procedure and preliminary evidence for two subunits and one FAD.

Authors:  N Minamiura; K T Yasunobu
Journal:  Arch Biochem Biophys       Date:  1978-08       Impact factor: 4.013

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  130 in total

Review 1.  Monoamine oxidase in neuropsychiatry and behavior.

Authors:  J C Shih; R F Thompson
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B.

Authors:  D P Holschneider; K Chen; I Seif; J C Shih
Journal:  Brain Res Bull       Date:  2001-11-15       Impact factor: 4.077

3.  Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography.

Authors:  S M Aquilonius; S S Jossan; J G Ekblom; H Askmark; P G Gillberg
Journal:  J Neural Transm Gen Sect       Date:  1992

4.  Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B.

Authors:  Kevin Chen; Xiao-Ming Ou; Jason Boyang Wu; Jean C Shih
Journal:  Mol Pharmacol       Date:  2010-10-27       Impact factor: 4.436

Review 5.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

6.  Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice.

Authors:  Marco Bortolato; Kevin Chen; Sean C Godar; Gao Chen; Weihua Wu; Igor Rebrin; Mollee R Farrell; Anna L Scott; Cara L Wellman; Jean C Shih
Journal:  Neuropsychopharmacology       Date:  2011-08-10       Impact factor: 7.853

7.  Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex.

Authors:  M D Galva; G P Bondiolotti; M Olasmaa; G B Picotti
Journal:  J Neural Transm Gen Sect       Date:  1995

8.  Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.

Authors:  Pei Chuan Li; Imran N Siddiqi; Anja Mottok; Eric Y Loo; Chieh Hsi Wu; Wendy Cozen; Christian Steidl; Jean Chen Shih
Journal:  J Pathol       Date:  2017-09-05       Impact factor: 7.996

Review 9.  Selective MAO-B inhibitors: a lesson from natural products.

Authors:  Simone Carradori; Melissa D'Ascenzio; Paola Chimenti; Daniela Secci; Adriana Bolasco
Journal:  Mol Divers       Date:  2013-11-12       Impact factor: 2.943

10.  In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain.

Authors:  N Bel; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.